Cell BioEngines announces exclusive licencing agreement for cancer cure
January 26, 2023Medical Communications
US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …
t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells
January 26, 2023Business Services
26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …
Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease
January 26, 2023Business Services
26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …
First CAR T-cell therapy recommended for routine use on the NHS in England
January 26, 2023Business Services
26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases
January 26, 2023Business Services
Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …
Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition
January 26, 2023Business Services
MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …
US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections
January 25, 2023Business Services
Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …
Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa
January 25, 2023Business Services
LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …
STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference
January 25, 2023Business Services
25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …
Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022
January 25, 2023Business Services
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …
Sosei Heptares Webinar Presentation for FY2022 Financial Results
January 25, 2023Business Services
Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug
January 25, 2023Medical Communications
Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …
Eli Lilly plans to invest $450m at production site in Research Triangle Park
January 25, 2023Manufacturing and Production
US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …
Poxel given EC’s Orphan Drug Designation for rare metabolic disorders
January 25, 2023Research and Development
Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1
January 25, 2023Medical Communications
US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …
finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation
January 24, 2023Business Services
London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …
UK seeing exodus of R&D activity, research reveals
January 24, 2023Business Services
London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …
Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence
January 24, 2023Business Services
London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …
2022 Novo Holdings Seed Investments team Review/Business Update
January 24, 2023Business Services
Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …
Global Company Foot Science International Choose Onyx Health
January 24, 2023Business Services
Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …
Latest content
FibroFind appoints Lee Borthwick as CEO
